Home
About us
Technology
Pipeline
Media
News Announcement
Careers
EN CN
Fapon Fapon Biotech VetMew
Home
About us
Technology
Pipeline

Media
News
Careers
CN
EN
Fapon Fapon Biotech VetMew

News

2025-06-11

Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025

Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the BIO International Convention 2025 (BIO 2025), taking place June 16-19 in Boston Convention & Exhibition Center.
Read more

2023-02-22

Fapon Biopharma’s Anti-CD47 Antibody FP002 Earns IND Approval from FDA

(Feb. 22, 2023, Shenzhen, China) Fapon Biopharma, an innovative biotech company, announced today that its Investigational New Drug (IND) application of FP002.
Read more
12
About us Technology Pipeline Media Careers

+86 769 86088555, Ext. 0

biopharma@fapon.com

3F–4F, Building 10, Dongguan–Taiwan Bio-Tech Collaborative Incubation Center, 1 Taoyuan Road, Dongguan, Guangdong Province, China

Scan and follow Fapon LinkedIn Page

© Guangdong Fapon Biopharma Inc. All rights reserved.

Guangdong ICP No. 2024177910-1

Links：

Fapon Fapon Biotech VetMew
Privacy policy